C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,077 | -28,361 | -132,493 | -97,739 | -70,702 |
| Depreciation Amortization | -2,034 | -817 | -1,499 | -962 | -367 |
| Accounts receivable | 10,632 | -1,799 | -10,327 | 973 | 445 |
| Accounts payable and accrued liabilities | -533 | 182 | 273 | 104 | 941 |
| Other Working Capital | 9,225 | 3,357 | -6,938 | -10,341 | 3,155 |
| Other Operating Activity | 5,695 | 9,320 | 44,146 | 25,136 | 14,406 |
| Operating Cash Flow | $-23,092 | $-18,118 | $-106,838 | $-82,829 | $-52,122 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -174,972 | -107,748 | 160,057 | -92,020 | -60,078 |
| PPE Investments | -197 | N/A | -1,708 | -1,551 | -951 |
| Sale Of Investment | 110,067 | 54,352 | N/A | 219,975 | 129,708 |
| Investing Cash Flow | $-65,102 | $-53,396 | $158,349 | $126,404 | $68,679 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -12,500 | -12,500 | -1,500 |
| Common Stock Issued | 34,743 | 34,608 | 57,731 | 58 | 58 |
| Common Stock Repurchased | -109 | -109 | -110 | -110 | -94 |
| Other Financing Activity | 84 | 84 | 368 | 369 | 106 |
| Financing Cash Flow | $34,718 | $34,583 | $45,489 | $-12,183 | $-1,430 |
| Beginning Cash Position | 130,033 | 130,033 | 33,033 | 33,033 | 33,033 |
| End Cash Position | 76,557 | 93,102 | 130,033 | 64,425 | 48,160 |
| Net Cash Flow | $-53,476 | $-36,931 | $97,000 | $31,392 | $15,127 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,092 | -18,118 | -106,838 | -82,829 | -52,122 |
| Capital Expenditure | -197 | N/A | -1,708 | -1,551 | -951 |
| Free Cash Flow | -23,289 | -18,118 | -108,546 | -84,380 | -53,073 |